Medicine & Life Sciences
Breast Neoplasms
100%
Vinorelbine
21%
Neoplasms
19%
Trastuzumab
18%
Drug Therapy
18%
Doxorubicin
17%
Cyclophosphamide
17%
Therapeutics
17%
Hepatocellular Carcinoma
15%
human ERBB2 protein
14%
Tamoxifen
14%
Fluorouracil
13%
Survival
12%
Anthracyclines
10%
Kaposi's Sarcoma
10%
liposomal doxorubicin
10%
Megestrol Acetate
10%
Toremifene
10%
Estrogen Receptors
9%
Safety
9%
Adjuvant Chemotherapy
9%
Uganda
9%
Clinical Trials
8%
Hormones
8%
Vincristine
8%
Appointments and Schedules
8%
Agranulocytosis
8%
Hepatitis Antigens
8%
Capecitabine
8%
Docetaxel
7%
Aromatase Inhibitors
7%
Combination Drug Therapy
7%
Anastrozole
7%
Dexrazoxane
7%
Serum
6%
Group Psychotherapy
6%
Methotrexate
6%
Phase II Clinical Trials
6%
Pharmacokinetics
6%
Bone and Bones
6%
Levamisole
6%
Estrogens
6%
Zoledronic Acid
5%
Clinical Trials, Phase I
5%
Neoplasm Metastasis
5%
Mitoxantrone
5%
imidazole
5%
alpha-Fetoproteins
5%
Paclitaxel
5%
Taxoids
5%